Mayur Ian Somaiya
CIK 1760303 · Chief Financial Officer · last filed 2026-01-22
Mayur Ian Somaiya is a Chief Financial Officer who has filed 12 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for NAMSW, was dated Jan 22, 2026. Across all open-market trades the lifetime net is −$3.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.10M
2
12
-$3.61M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NAMSW | Chief Financial Officer | 58,382 | $18.80 | $1.10M | -$3.43M | 6 | 2026-01-22 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Chief Financial Officer | 3,473 | $1.48 | $5.1K | -$180.0K | 6 | 2020-12-16 |
Recent Filings
12 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-22 | NAMSW | Mixed | — | -$2.33M | EDGAR |
| 2026-01-07 | NAMSW | Mixed | +20,382 | -$170.2K | EDGAR |
| 2025-01-29 | NAMSW | Mixed | — | $573.0K | EDGAR |
| 2025-01-07 | NAMSW | Grant (A) | +38,000 | $0 | EDGAR |
| 2025-01-06 | NAMSW | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | NAMSW | Grant (A) | — | $0 | EDGAR |
| 2020-12-16 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Mixed | — | -$58.2K | EDGAR |
| 2020-12-11 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-19 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Mixed | −1,666 | -$98.2K | EDGAR |
| 2020-03-27 | TCR2 THERAPEUTICS INC. (TCRR) Delisted | Grant (A) | +3,139 | $36.1K | EDGAR |